Related Experiment Videos
Quantitative quality control of antiglobulin reagents
Clinical and Laboratory Haematology
|January 1, 1983
Summary
Radioimmunoassays quantified antibodies in antiglobulin reagents, revealing significant variations in antibody concentrations and binding constants. Some reagents had suboptimal antibody levels for effective agglutination.
Area of Science:
- Immunology
- Biochemistry
Background:
- Polyspecific antiglobulin reagents are crucial in serological testing.
- Quantifying specific antibody content and binding affinity is essential for reagent quality control.
Purpose of the Study:
- To develop and validate double antibody radioimmunoassays for quantifying anti-IgG, anti-C3, anti-C3c, anti-C3d, and anti-C4 antibodies.
- To determine the binding constants of these antibodies.
- To assess the quality and potency of commercial and public antiglobulin reagents.
Main Methods:
- Development of double antibody radioimmunoassays.
- Quantification of anti-IgG, anti-C3, anti-C3c, anti-C3d, and anti-C4 antibodies in 53 polyspecific antiglobulin reagents.
- Determination of antibody binding constants.
- Comparison of quantitative assay results with serological potency assessments.
Main Results:
- Significant variations in antibody concentrations were observed across commercial and public reagents.
- Public reagents showed a wider range of concentrations, particularly for anti-C3 and anti-C3c.
- Mean binding constants for commercial anti-IgG, anti-C3, anti-C3c, anti-C3d, and anti-C4 were determined.
- Suboptimal concentrations of anti-IgG, anti-C3, and anti-C3c were found in several reagents, potentially impacting agglutination efficacy.
Conclusions:
- The developed radioimmunoassays effectively quantify specific antibodies and their binding constants in antiglobulin reagents.
- There is considerable variability in the composition and potency of antiglobulin reagents from different sources.
- Quality control measures are necessary to ensure reagents contain adequate antibody concentrations for reliable serological testing.